Adherence, Medication, Adherence, Patient, HIV/AIDS
Conditions
Brief summary
1. Determine the dose-response relationship between a cash transfer amount and HIV viral suppression at 6 months 2. Identify the most effective cash transfer size to increase the proportion of people living with HIV infection (PLHIV) retained in care and with suppressed viral load (\<1000 copies/ml) after 6 months. (This amount will be further evaluated in a cluster randomized trial in Phase 2).
Detailed description
Participants in the control group will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS. The study has two active intervention arms: 1. The opportunity to earn 10,000 TZS/month (\ $4.50) for up to 6 months conditional on visit attendance, and 2. The opportunity to earn 22,500 TZS/month (\ $10.00) for up to 6 months conditional on visit attendance In both intervention arms, cash transfers will be delivered a maximum of once monthly, spaced ≥28 days apart, for up to six months and delivered via an automatic mobile money system linked to a biometric identification system.
Interventions
Participants in this arm will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS plus the opportunity to earn 10,000 TZS/month conditional on visit attendance.
Participants in this arm will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS plus the opportunity to earn 22,500 TZS/month conditional on visit attendance.
Sponsors
Study design
Masking description
Participants in the cash transfer arms will be masked to the knowledge that there are two cash value arms.
Eligibility
Inclusion criteria
* ≥18 years * Living with HIV infection * Initiated antiretroviral therapy ≤1 month prior to enrollment in the study
Exclusion criteria
\- Participants who do no provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HIV viral suppression at 6 months | 6 months | \<1000 copies/ml |
Countries
Tanzania